Genetic Analysis AS Statistics

Total Valuation

Genetic Analysis AS has a market cap or net worth of SEK 23.51 million. The enterprise value is 21.00 million.

Market Cap	23.51M
Enterprise Value	21.00M

Important Dates

The next estimated earnings date is Monday, February 17, 2025.

Earnings Date	Feb 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Genetic Analysis AS has 49.38 million shares outstanding. The number of shares has increased by 108.50% in one year.

Current Share Class	n/a
Shares Outstanding	49.38M
Shares Change (YoY)	+108.50%
Shares Change (QoQ)	+17.14%
Owned by Insiders (%)	10.28%
Owned by Institutions (%)	12.05%
Float	13.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.29
PB Ratio	1.03
P/TBV Ratio	3.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.06
EV / Sales	1.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.33

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.38.

Current Ratio	2.26
Quick Ratio	2.10
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	-0.54
Interest Coverage	-28.05

Financial Efficiency

Return on equity (ROE) is -80.72% and return on invested capital (ROIC) is -38.38%.

Return on Equity (ROE)	-80.72%
Return on Assets (ROA)	-29.76%
Return on Capital (ROIC)	-38.38%
Revenue Per Employee	904,082
Profits Per Employee	-940,744
Employee Count	21
Asset Turnover	0.47
Inventory Turnover	2.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.78% in the last 52 weeks. The beta is 1.80, so Genetic Analysis AS's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	-27.78%
50-Day Moving Average	0.53
200-Day Moving Average	0.71
Relative Strength Index (RSI)	45.33
Average Volume (20 Days)	52,525

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genetic Analysis AS had revenue of SEK 18.99 million and -19.76 million in losses. Loss per share was -0.38.

Revenue	18.99M
Gross Profit	15.44M
Operating Income	-19.39M
Pretax Income	-19.76M
Net Income	-19.76M
EBITDA	-19.61M
EBIT	-19.39M
Loss Per Share	-0.38

Full Income Statement

Balance Sheet

The company has 10.98 million in cash and 8.50 million in debt, giving a net cash position of 2.48 million or 0.05 per share.

Cash & Cash Equivalents	10.98M
Total Debt	8.50M
Net Cash	2.48M
Net Cash Per Share	0.05
Equity (Book Value)	22.56M
Book Value Per Share	0.46
Working Capital	11.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.84 million and capital expenditures 660, giving a free cash flow of -15.84 million.

Operating Cash Flow	-15.84M
Capital Expenditures	660
Free Cash Flow	-15.84M
FCF Per Share	-0.32

Full Cash Flow Statement

Margins

Gross margin is 81.35%, with operating and profit margins of -102.13% and -104.06%.

Gross Margin	81.35%
Operating Margin	-102.13%
Pretax Margin	-104.06%
Profit Margin	-104.06%
EBITDA Margin	-103.29%
EBIT Margin	-102.13%
FCF Margin	n/a

Dividends & Yields

Genetic Analysis AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-108.50%
Shareholder Yield	-108.50%
Earnings Yield	-84.02%
FCF Yield	-67.36%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genetic Analysis AS has an Altman Z-Score of -0.17. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.17
Piotroski F-Score	n/a